Published in Stem Cell Week, June 25th, 2007
"The use of Nucleofector electroporator (Amaxa biosystems, Germany) in combination with medium-contained G418 provided a high efficiency of gene delivery for advanced selection. Neucleofected cells were plated on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
Source: Stem Cell Week (2007-06-25)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.